Popular on EntSun
- Could You Make a 2026 World Cup Squad? A New Free Tool Will Tell You Where You'd Sit on Any National Team's Bench in 90 Seconds - 238
- Milo3D.ai Launches Free AI 3D Model Generator That Turns Text and Images Into Game-Ready 3D Assets in Seconds - 177
- UK Financial Ltd Audits Full Ethereum Architecture Verifies Corporate Wallets and 19-Token Ecosystem Ahead of CoinMarketCap Filing for Global Ranking - 154
- Federal indictments bring new scrutiny to SPLC practices and highlight the real‑world impact of its designations on nonprofit groups, including NCFM - 150
- Blank Space: The Unofficial Taylor Swift Tribute Brings Eras Tour Magic To Cities Across America - 131
- Speaker and Certified Coach Syrena N. Williams Debuts Powerful New Book on Healing, Identity, and Wholeness - 129
- UK Financial Ltd Executes 100% Success Rate on All ERC-3643 Transfers to Coin Holders of MayaCat Regulated Security Token and Maya Preferred PRA - 129
- WOA Entertainment Group Announces Captivating New EP 'The Fools Gold' by Ambient-Folk Project Leave the Bones - 125
- Boston Industrial Solutions Introduces New Natron® 310 Hyper White UV Ink for Enhanced Printing Performance - 124
- New Patriotic Song "America 250" Celebrates Nation's Semiquincentennial Ahead of July 4th - 122
Similar on EntSun
- Record Revenue Growth, AI-Driven Healthcare Innovation, Expanding Proprietary Brand and Targeting $200 Million Revenue By 2029: Cosmos Health Inc
- Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029
- FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP
- Accelerating Toward Commercialization as FDA Momentum, AI Neurotherapy & Manufacturing Expansion Drive Multi-Catalyst Growth Story; N A S D A Q: NRXP
- Medical Experts Highlight the Importance of Second Opinions in Death Investigations
- NRx Pharmaceuticals (N A S D A Q: NRXP) Accelerates Into National Spotlight as Manufacturing Launch, Federal Policy & AI-Driven Breakthroughs Converge
- More Life Summit 2026 Announces Gary Brecka & Mr. Olympia Derek Lunsford as First Speakers for Miami Event
- Presidential Acceleration of Psychedelic Therapies Enters a Defining Moment as Federal Policy, FDA Alignment & Breakthrough Neurotechnology Converge
- Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
- AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)
PurMa Biologics Publishes Free Mycoplasma Detection Protocol for Cell Culture Researchers
EntSun News/11095100
Oklahoma City biotech company releases step-by-step mycoplasma detection and elimination protocol
OKLAHOMA CITY - EntSun -- OKLAHOMA CITY, OK — PurMa Biologics, a leading manufacturer of cell culture reagents and biologics services, has published a comprehensive mycoplasma detection and elimination protocol available free to the scientific community via protocols.io.
Mycoplasma contamination is estimated to affect up to 35% of cell cultures worldwide, making it one of the most significant threats to research reproducibility and integrity. Left undetected, mycoplasma can alter cell behavior, gene expression, and experimental results, leading to costly research failures.
The protocol, developed by PurMa Biologics' team of scientists with over 30 years of combined expertise in cell culture and protein biochemistry, outlines a clear 5-step process for detecting and eliminating mycoplasma contamination using validated reagents.
"We want to give researchers the tools and knowledge they need to maintain clean, reliable cell cultures," said Seifollah Azadi, Founder and CEO of PurMa Biologics. "This protocol is part of our commitment to supporting the scientific community beyond just supplying reagents."
More on EntSun News
PurMa Biologics offers over 3,000 cell culture reagents including culture media, buffers, serums, trypsin, transfection reagents, and mycoplasma detection and elimination kits. The company also provides custom biotech services including monoclonal antibody development, protein expression and purification, and gene cloning.
The free protocol is available at: http://www.protocols.io/workspaces/purma-biologics
For more information about PurMa Biologics and their full catalog of cell culture reagents, visit http://www.purmabiologics.com or call 1-866-720-6116.
About PurMa Biologics:
PurMa Biologics is an Oklahoma City-based biotechnology company specializing in cell culture reagents and biologics services. With over 30 years of combined expertise, PurMa Biologics serves research institutions, biotechnology companies, and laboratories worldwide with 3,000+ high-quality reagents and custom research services.
Mycoplasma contamination is estimated to affect up to 35% of cell cultures worldwide, making it one of the most significant threats to research reproducibility and integrity. Left undetected, mycoplasma can alter cell behavior, gene expression, and experimental results, leading to costly research failures.
The protocol, developed by PurMa Biologics' team of scientists with over 30 years of combined expertise in cell culture and protein biochemistry, outlines a clear 5-step process for detecting and eliminating mycoplasma contamination using validated reagents.
"We want to give researchers the tools and knowledge they need to maintain clean, reliable cell cultures," said Seifollah Azadi, Founder and CEO of PurMa Biologics. "This protocol is part of our commitment to supporting the scientific community beyond just supplying reagents."
More on EntSun News
- Discover the Perfect Venue for Ceremony Only Weddings in Central Florida
- Elklook Launches Special Father's Day Celebration
- DuoKey Launches Quantum Risk Score to Help Enterprises Prioritise Post-Quantum Cryptography Migration
- Top 5 Most Reliable Used Vans in the UK in 2026
- Dominican Fashion Designer Raiza Bonaparte presents the Sovereign Despampanante Collection at the Library of Congress
PurMa Biologics offers over 3,000 cell culture reagents including culture media, buffers, serums, trypsin, transfection reagents, and mycoplasma detection and elimination kits. The company also provides custom biotech services including monoclonal antibody development, protein expression and purification, and gene cloning.
The free protocol is available at: http://www.protocols.io/workspaces/purma-biologics
For more information about PurMa Biologics and their full catalog of cell culture reagents, visit http://www.purmabiologics.com or call 1-866-720-6116.
About PurMa Biologics:
PurMa Biologics is an Oklahoma City-based biotechnology company specializing in cell culture reagents and biologics services. With over 30 years of combined expertise, PurMa Biologics serves research institutions, biotechnology companies, and laboratories worldwide with 3,000+ high-quality reagents and custom research services.
Source: PurMa Biologics
0 Comments
Latest on EntSun News
- Warm, Dry Summer Forecast Points to a Stronger Wasp and Yellowjacket Season Across the Pacific Northwest
- Qscription Technologies Appoints Anurag Velekkatt Sunil Kumar to Drive Enterprise Scale
- SafeBets Named Presenting Sponsor of IMCX 2026, Bringing Its No-Deposit Prediction Platform to the Creator Economy's Deal-Making Conference
- Bay Street Yard to host annual Fourth of July Party
- A New Pulse for Cardiac Care in Baltimore: St. Elizabeth Rehab & Nursing Welcomes Dr. Hakim Uqdah and Expands Advanced Heart Program
- Inframark–Slater Joint Venture Selected to Manage Fulton County Wastewater Operations
- Cancun International Airport Reports Strong Start to Summer 2026 Travel Season
- Freedomtech Solutions Launches the World's First Pre‑Installed Agentic AI Server — Instant, Sovereign, Infrastructure‑Native Intelligence
- GitKraken Introduces Code Flow, a Framework for Software Development in the Agentic Era
- RIGHT CARS Announces Landmark African Expansion Through Strategic Collaboration Agreement Across Eight Nations
- From Idaho to Hollywood: A True Haunting's Path to the Screen
- The Railyard Event & Conference Center Targets July Opening in Downtown Elkins
- Connecticut Picture Cars Delivers Authentic Movie Car Rentals Statewide
- Boston Industrial Solutions' Natron® 717N Series UV LED Ink Receives CPSIA Certification
- purelyIV Expands Mobile IV Therapy to Jackson, MI and Launches PlaqueX® IV Therapy
- Leimert Juneteenth Community Celebration Set for Friday, June 19, in Leimert Park Village
- UK Financial Ltd Publishes Maya Preferred Public Proof Package and CoinMarketCap Supply Verification Evidence
- Advancing High-Potential Nevada Critical Minerals Portfolio as Major Drill Program Nears Assay Results: Glenstar Minerals: Stock Symbol: GSTRF
- Allstream Energy Partners to Host 6th Executive Networking After 2026 Energy Projects Conference
- Jorden Lacy Jackson Quietly Releases a Music Trilogy